HYPOPROTHROMBINEMIA ASSOCIATED WITH CEFAMANDOLE

被引：41

作者：

RYMER, W ^{[1
]}

GREENLAW, CW ^{[1
]}

机构：

[1] HOLY CROSS HOSP,DEPT INT MED & HEMATOL ONCOL,FT LAUDERDALE,FL

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1980年 / 14卷 / 11期

关键词：

D O I：

10.1177/106002808001401106

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：780 / 783

页数：4

共 9 条

[1] HEMOSTATIC DEFECT PRODUCED BY CARBENICILLIN
BROWN, CH
NATELSON, EA
BRADSHAW, MW
WILLIAMS, TW
ALFREY, CP
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (06) : 265 - 270
[2] EFFECT OF CEFAMANDOLE NAFATE ON BLOOD-COAGULATION AND PLATELET-FUNCTION
CUSTER, GM
BRIGGS, BR
SMITH, RE
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (06) : 869 - 872
[3] HYPOPROTHROMBINAEMIA IN PATIENTS UNDERGOING PROLONGED INTENSIVE CARE
HAM, JM
[J]. MEDICAL JOURNAL OF AUSTRALIA, 1971, 2 (14) : 716 - &
[4] HOOPER CA, 1980, LANCET, V1, P39
[5] KLIPPEL AP, 1968, ARCH SURG-CHICAGO, V96, P266
[6] LERNER PI, 1974, NEW ENGL J MED, V290, P1324
[7] PINEO GF, 1973, CAN MED ASSOC J, V109, P880
[8] EXCRETION OF CEFAMANDOLE, CEFAZOLIN, AND CEPHALOTHIN INTO T-TUBE BILE
RATZAN, KR
BAKER, HB
LAUREDO, I
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 13 (06) : 985 - 987
[9] YUDIS M, 1972, LANCET, V2, P599